Metylsulfonylmetán (MSM)

Literatúra

  1. Gumina S, et al. Arginine L-alpha-ketoglutarate, methylsulfonylmethane, hydrolyzed type I collagen and bromelain in rotator cuff tear repair: a prospective randomized studyCurr Med Res Opin. (2012)
  2. Joksimovic N, et al. Efficacy and tolerability of hyaluronic acid, tea tree oil and methyl-sulfonyl-methane in a new gel medical device for treatment of haemorrhoids in a double-blind, placebo-controlled clinical trialUpdates Surg. (2012)
  3. Berardesca E, et al. Combined effects of silymarin and methylsulfonylmethane in the management of rosacea: clinical and instrumental evaluationJ Cosmet Dermatol. (2008)
  4. [No authors listed. Methylsulfonylmethane (MSM). MonographAltern Med Rev. (2003)
  5. Brien S, et al. Systematic review of the nutritional supplements dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) in the treatment of osteoarthritisOsteoarthritis Cartilage. (2008)
  6. Magnuson BA, Appleton J, Ames GB. Pharmacokinetics and distribution of {35S}methylsulfonylmethane following oral administration to ratsJ Agric Food Chem. (2007)
  7. El-Gindy A, et al. Reflectance near-infrared spectroscopic method with Chemometric techniques for simultaneous determination of Chondroitin, glucosamine, and methyl sulfonyl methaneJ AOAC Int. (2012)
  8. Tsui T, et al. Understanding the role of scientific evidence in consumer evaluation of natural health products for osteoarthritis an application of the means end chain approachBMC Complement Altern Med. (2012)
  9. Clark T, et al. Why are dimethyl sulfoxide and dimethyl sulfone such good solventsJ Mol Model. (2008)
  10. Williams KI, Burstein SH, Layne DS. Dimethyl sulfone: isolation from cows’ milkProc Soc Exp Biol Med. (1966)
  11. Pearson TW, Dawson HJ, Lackey HB. Natural occurring levels of dimethyl sulfoxide in selected fruits, vegetables, grains, and beveragesJ Agric Food Chem. (1981)
  12. GC-MS identification of dimethyl sulfone in cow’s milk and other livestock products.
  13. Smale BC, Lasater NJ, Hunter BT. Fate and metabolism of dimethyl sulfoxide in agricultural cropsAnn N Y Acad Sci. (1975)
  14. Egorin MJ, et al. Plasma concentrations and pharmacokinetics of dimethylsulfoxide and its metabolites in patients undergoing peripheral-blood stem-cell transplantsJ Clin Oncol. (1998)
  15. Engelke UF, et al. Dimethyl sulfone in human cerebrospinal fluid and blood plasma confirmed by one-dimensional (1)H and two-dimensional (1)H-(13)C NMRNMR Biomed. (2005)
  16. Burger BV, et al. Elemental sulfur identified in urine of cheetah, Acinonyx jubatusJ Chem Ecol. (2006)
  17. Apps P, Mmualefe L, McNutt JW. Identification of volatiles from the secretions and excretions of African wild dogs (Lycaon pictus)J Chem Ecol. (2012)
  18. Williams KI, Burstein SH, Layne DS. Metabolism of dimethyl sulfide, dimethyl sulfoxide, and dimethyl sulfone in the rabbitArch Biochem Biophys. (1966)
  19. Richmond VL. Incorporation of methylsulfonylmethane sulfur into guinea pig serum proteinsLife Sci. (1986)
  20. Elucidation of dimethylsulfone metabolism in rat using a 35S radioisotope tracer method.
  21. Cecil KM, et al. Methylsulfonylmethane observed by in vivo proton magnetic resonance spectroscopy in a 5-year-old child with developmental disorder: effects of dietary supplementationJ Comput Assist Tomogr. (2002)
  22. Lin A, et al. Accumulation of methylsulfonylmethane in the human brain: identification by multinuclear magnetic resonance spectroscopyToxicol Lett. (2001)
  23. Rose SE, et al. Detection of dimethyl sulfone in the human brain by in vivo proton magnetic resonance spectroscopyMagn Reson Imaging. (2000)
  24. Willemsen MA, et al. Methylsulfonylmethane (MSM) ingestion causes a significant resonance in proton magnetic resonance spectra of brain and cerebrospinal fluidNeuropediatrics. (2006)
  25. Rogovin JL. Accumulation of methylsulfonylmethane in the human brain: identification by multinuclear magnetic resonance spectroscopyToxicol Lett. (2002)
  26. Evans MS, Reid KH, Sharp JB Jr. Dimethylsulfoxide (DMSO) blocks conduction in peripheral nerve C fibers: a possible mechanism of analgesiaNeurosci Lett. (1993)
  27. Bal E, et al. The effects of gender difference on monocrotaline-induced pulmonary hypertension in ratsHum Exp Toxicol. (2013)
  28. Werchan PM, et al. Right ventricular performance after monocrotaline-induced pulmonary hypertensionAm J Physiol. (1989)
  29. Mohammadi S, et al. Protective effects of methylsulfonylmethane on hemodynamics and oxidative stress in monocrotaline-induced pulmonary hypertensive ratsAdv Pharmacol Sci. (2012)
  30. Parcell S. Sulfur in human nutrition and applications in medicineAltern Med Rev. (2002)
  31. Jin HF, et al. Effects of endogenous sulfur dioxide on monocrotaline-induced pulmonary hypertension in ratsActa Pharmacol Sin. (2008)
  32. Kantor ED, et al. Association between use of specialty dietary supplements and C-reactive protein concentrationsAm J Epidemiol. (2012)
  33. Klandorf H, et al. Dimethyl sulfoxide modulation of diabetes onset in NOD miceDiabetes. (1989)
  34. Brayton CF. Dimethyl sulfoxide (DMSO): a reviewCornell Vet. (1986)
  35. Feng L, et al. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharideJ Clin Invest. (1995)
  36. Kloesch B, et al. Dimethyl sulphoxide and dimethyl sulphone are potent inhibitors of IL-6 and IL-8 expression in the human chondrocyte cell line C-28/I2Life Sci. (2011)
  37. Kim YH, et al. The anti-inflammatory effects of methylsulfonylmethane on lipopolysaccharide-induced inflammatory responses in murine macrophagesBiol Pharm Bull. (2009)
  38. Ezaki J, et al. Assessment of safety and efficacy of methylsulfonylmethane on bone and knee joints in osteoarthritis animal modelJ Bone Miner Metab. (2013)
  39. Rizzo R, et al. Calcium, sulfur, and zinc distribution in normal and arthritic articular equine cartilage: a synchrotron radiation-induced X-ray emission (SRIXE) studyJ Exp Zool. (1995)
  40. Burdett N, McNeil JD. Difficulties with assessing the benefit of glucosamine sulphate as a treatment for osteoarthritisInt J Evid Based Healthc. (2012)
  41. Cordoba F, Nimni ME. Chondroitin sulfate and other sulfate containing chondroprotective agents may exhibit their effects by overcoming a deficiency of sulfur amino acidsOsteoarthritis Cartilage. (2003)
  42. Barrager E, et al. A multicentered, open-label trial on the safety and efficacy of methylsulfonylmethane in the treatment of seasonal allergic rhinitisJ Altern Complement Med. (2002)
  43. Gaby AR. Methylsulfonylmethane as a treatment for seasonal allergic rhinitis: more data needed on pollen counts and questionnaireJ Altern Complement Med. (2002)
  44. Barrager E, Schauss AG. Methylsulfonylmethane as a treatment for seasonal allergic rhinitis: additional data on pollen counts and symptom questionnaireJ Altern Complement Med. (2003)
  45. Kalman DS, et al. Influence of methylsulfonylmethane on markers of exercise recovery and performance in healthy men: a pilot studyJ Int Soc Sports Nutr. (2012)
  46. Barmaki S, et al. Effect of methylsulfonylmethane supplementation on exercise – Induced muscle damage and total antioxidant capacityJ Sports Med Phys Fitness. (2012)
  47. Nakhostin-Roohi B, et al. Effect of chronic supplementation with methylsulfonylmethane on oxidative stress following acute exercise in untrained healthy menJ Pharm Pharmacol. (2011)
  48. Kim LS, et al. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trialOsteoarthritis Cartilage. (2006)
  49. Usha PR, Naidu MU. Randomised, Double-Blind, Parallel, Placebo-Controlled Study of Oral Glucosamine, Methylsulfonylmethane and their Combination in OsteoarthritisClin Drug Investig. (2004)
  50. Debbi EM, et al. Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled studyBMC Complement Altern Med. (2011)
  51. Geba GP, et al. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trialJAMA. (2002)
  52. Notarnicola A, et al. The “MESACA” study: methylsulfonylmethane and boswellic acids in the treatment of gonarthrosisAdv Ther. (2011)
  53. Joung YH, et al. MSM enhances GH signaling via the Jak2/STAT5b pathway in osteoblast-like cells and osteoblast differentiation through the activation of STAT5b in MSCsPLoS One. (2012)
  54. Jafari N, et al. Cytotoxicity of methylsulfonylmethane on gastrointestinal (AGS, HepG2, and KEYSE-30) cancer cell linesJ Gastrointest Cancer. (2012)
  55. Lim EJ, et al. Methylsulfonylmethane suppresses breast cancer growth by down-regulating STAT3 and STAT5b pathwaysPLoS One. (2012)
  56. Caron JM, et al. Methyl sulfone induces loss of metastatic properties and reemergence of normal phenotypes in a metastatic cloudman S-91 (M3) murine melanoma cell linePLoS One. (2010)
  57. Yi HK, et al. Expression of the insulin-like growth factors (IGFs) and the IGF-binding proteins (IGFBPs) in human gastric cancer cellsEur J Cancer. (2001)
  58. Hwang PH, et al. PTEN/MMAC1 enhances the growth inhibition by anticancer drugs with downregulation of IGF-II expression in gastric cancer cellsExp Mol Med. (2005)
  59. Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescenceInt J Biochem Cell Biol. (2005)
  60. Lleonart ME, Artero-Castro A, Kondoh H. Senescence induction; a possible cancer therapyMol Cancer. (2009)
  61. Roninson IB. Tumor cell senescence in cancer treatmentCancer Res. (2003)
  62. Amirshahrokhi K, Bohlooli S, Chinifroush MM. The effect of methylsulfonylmethane on the experimental colitis in the ratToxicol Appl Pharmacol. (2011)
  63. Tripathi R, et al. Effect of topical application of methylsulfonylmethane (MSM), EDTA on pitting edema and oxidative stress in a double blind, placebo-controlled studyCell Mol Biol (Noisy-le-grand). (2011)
  64. Berardesca E, et al. Clinical and instrumental evaluation of skin improvement after treatment with a new 50% pyruvic acid peelDermatol Surg. (2006)
  65. Kurihara-Bergstrom T, Flynn GL, Higuchi WI. Physicochemical study of percutaneous absorption enhancement by dimethyl sulfoxide: kinetic and thermodynamic determinants of dimethyl sulfoxide mediated mass transfer of alkanolsJ Pharm Sci. (1986)
  66. Mode of action of penetration enhancers in human skin.
  67. KLIGMAN AM. TOPICAL PHARMACOLOGY AND TOXICOLOGY OF DIMETHYL SULFOXIDE. 1JAMA. (1965)
  68. Sweeney TM, Downes AM, Matoltsy AG. The effect of dimethyl sulfoxide on the epidermal water barrierJ Invest Dermatol. (1966)
  69. Montes LF, et al. Ultrastructural changes in the horny layer following local application of dimethyl sulfoxideJ Invest Dermatol. (1967)
  70. Shackleford JM, Yielding KL. Ultrastructural studies of barrier restoration in epidermis of hairless mice following dimethyl sulfoxide applicationJ Cutan Pathol. (1984)
  71. Song Y, et al. Investigation of iminosulfuranes as novel transdermal penetration enhancers: enhancement activity and cytotoxicityPharm Res. (2005)
  72. Zhang M, et al. Assessment of methylsulfonylmethane as a permeability enhancer for regional EDTA chelation therapyDrug Deliv. (2009)
  73. Zhang M, et al. Topical metal chelation therapy ameliorates oxidation-induced toxicity in diabetic cataractJ Toxicol Environ Health A. (2011)
  74. Horváth K, et al. Toxicity of methylsulfonylmethane in ratsFood Chem Toxicol. (2002)
  75. Magnuson BA, et al. Oral developmental toxicity study of methylsulfonylmethane in ratsFood Chem Toxicol. (2007)